Jordi Labs was acquired by RQM+, a professional services firm with a focus on healthcare, for an unknown price. By adding new skills, the purchase will strengthen RQM+’s regulatory and manufacturing services for the medical industry.
According to Statista’s analysis, the market for medical technology will earn $575.80 billion in revenue in 2022. Medical devices are predicted to be the market’s largest category, with a market volume of $455.10 billion in 2022 and revenue growth of 5.95% per year through 2027, reaching a market volume of $768.80 billion during that period. This suggests that there is a rising demand for consultants who can help customers take full advantage of this evolving market.
RQM+ is a professional services firm with locations in Pennsylvania’s Monroeville as well as the United Kingdom’s Nottingham and Switzerland’s Basel. The firm describes itself as the largest clinical and regulatory consulting organization in the world with a focus on medical devices and diagnostics, according to its LinkedIn page. It also offers a comprehensive range of MedTech services that facilitate market access for diagnostics and medical devices across the whole product lifecycle.
In order to extend its capabilities and satisfy rising client demand in North America and Europe, RQM+ has acquired Jordi Labs. The Mansfield, Massachusetts-based company provides MedTech companies with failure analysis, complex product deformulation, chemical characterization, and contaminant and failure investigations.
RQM+ is thrilled to now provide expanded proprietary testing services, allowing our customers the shortest path to regulatory approvals, according to CEO Margaret Keegan. The only MedTech service provider with roots in regulatory strategy dating back more than 40 years is RQM+.
“We are happy to now be a part of the RQM+ solution that takes firms to market faster with our great track record of rapid testing findings that satisfy the demanding standards of regulators throughout the world,” said Mark Jordi, president of Jordi Labs.
Kirkland and Ellis provided legal counsel to Linden Capital Partners. Harris Williams acted as Jordi Labs’s representative.
